Population pharmacokinetics of gentamicin in hospitalized patients receiving once-daily dosing
- 31 March 2004
- journal article
- research article
- Published by Elsevier in International Journal of Antimicrobial Agents
- Vol. 23 (3) , 291-294
- https://doi.org/10.1016/j.ijantimicag.2003.07.010
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Antibiotic Resistance Among Gram-Negative Bacilli in US Intensive Care UnitsJAMA, 2003
- Optimizing Aminoglycoside Therapy for Nosocomial Pneumonia Caused by Gram-Negative BacteriaAntimicrobial Agents and Chemotherapy, 1999
- Influence of diagnostic and treatment factors in the population pharmacokinetics of gentamicinJournal of Clinical Pharmacy & Therapeutics, 1998
- Pharmacokinetics of gentamicin at traditional versus high doses: implications for once-daily aminoglycoside dosingAntimicrobial Agents and Chemotherapy, 1997
- Experience with a once-daily aminoglycoside program administered to 2,184 adult patientsAntimicrobial Agents and Chemotherapy, 1995
- Building population pharmacokineticpharmacodynamic models. I. Models for covariate effectsJournal of Pharmacokinetics and Biopharmaceutics, 1992
- A three-step approach combining bayesian regression and NONMEM population analysis: Application to midazolamJournal of Pharmacokinetics and Biopharmaceutics, 1991
- Association of aminoglycoside plasma levels with therapeutic outcome in gram-negative pneumoniaThe American Journal of Medicine, 1984
- The Association of Aminoglycoside Plasma Levels with Mortality in Patients with Gram-Negative BacteremiaThe Journal of Infectious Diseases, 1984
- Prediction of Creatinine Clearance from Serum CreatinineNephron, 1976